Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid bindingPäll, Taavi; Gad, A.; Kasak, L.; Drews, Monika; Strömblad, Sraffan; Kogerman, PriitOncogene2004 / 47, p. 7874-7881 https://www.nature.com/articles/1208083

Studies of CD44 hyaluronan binding domain as novel angiogenesis inhibitor = CD44 hüaluroonhapet siduv domään kui uudne angiogeneesi inhibiitorPäll, Taavi2013 https://www.ester.ee/record=b2992362*est

The role of CD44 in the control of endothelial cell proliferation and angiogenesis = CD44 roll angiogeneesis ja endoteelirakkude jagunemisesPink, Anne2016 http://www.ester.ee/record=b4610555*est